-
Something wrong with this record ?
The Different Insulin-Sensitising and Anti-Inflammatory Effects of Palmitoleic Acid and Oleic Acid in a Prediabetes Model
D. Miklankova, I. Markova, M. Hüttl, B. Stankova, H. Malinska
Language English Country England, Great Britain
Document type Journal Article
PubMed
36147256
DOI
10.1155/2022/4587907
Knihovny.cz E-resources
- MeSH
- Adiponectin MeSH
- Anti-Inflammatory Agents MeSH
- Cytokines MeSH
- Diabetes Mellitus, Type 2 * MeSH
- Glucagon MeSH
- Glucose metabolism MeSH
- Insulin metabolism MeSH
- Insulin Resistance * MeSH
- Rats MeSH
- Oleic Acid pharmacology MeSH
- Arachidonic Acids MeSH
- Fatty Acids, Monounsaturated pharmacology therapeutic use MeSH
- Fatty Acids, Nonesterified MeSH
- Lipoprotein Lipase MeSH
- Fatty Acids metabolism MeSH
- Prediabetic State * drug therapy MeSH
- Inflammation MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
Introduction: Monounsaturated fatty acids (MUFA) are understood to have therapeutic and preventive effects on chronic complications associated with type 2 diabetes mellitus (T2DM); however, there are differences between individual MUFAs. Although the effects of palmitoleic acid (POA) are still debated, POA can regulate glucose homeostasis, lipid metabolism, and cytokine production, thus improving metabolic disorders. In this study, we investigated and compared the metabolic effects of POA and oleic acid (OA) supplementation on glucose and lipid metabolism, insulin sensitivity, and inflammation in a prediabetic model, the hereditary hypertriglyceridemic rat (HHTg). HHTg rats exhibiting genetically determined hypertriglyceridemia, insulin resistance, and impaired glucose tolerance were fed a standard diet. POA and OA were each administered intragastrically at a dose of 100 mg/kg b.wt. for four weeks. Results: Supplementation with both MUFAs significantly elevated insulin and glucagon levels, but only POA decreased nonfasting glucose. POA-treated rats showed elevated circulating NEFA associated with increased lipolysis, lipoprotein lipase gene expression, and fatty acid reesterification in visceral adipose tissue (VAT). The mechanism of improved insulin sensitivity of peripheral tissues (measured as insulin-stimulated lipogenesis and glycogenesis) in POA-treated HHTg rats could contribute increased circulating adiponectin and omentin levels together with elevated FADS1 gene expression in VAT. POA-supplemented rats exhibited markedly decreased proinflammatory cytokine production by VAT, which can alleviate chronic inflammation. OA-supplemented rats exhibited decreased arachidonic acid (AA) profiles and decreased proinflammatory AA-derived metabolites (20-HETE) in membrane phospholipids of peripheral tissues. Slightly increased FADS1 gene expression after OA along with increased adiponectin production by VAT was reflected in slightly ameliorated adipose tissue insulin sensitivity (increased insulin-stimulated lipogenesis). Conclusions: Our results show that POA served as a lipokine, ameliorating insulin sensitivity in peripheral tissue and markedly modulating the metabolic activity of VAT including cytokine secretion. OA had a beneficial effect on lipid metabolism and improved inflammation by modulating AA metabolism.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22024422
- 003
- CZ-PrNML
- 005
- 20221031100259.0
- 007
- ta
- 008
- 221017s2022 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1155/2022/4587907 $2 doi
- 035 __
- $a (PubMed)36147256
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Miklankova, Denisa $u Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $u First Faculty of Medicine, Charles University, Prague, Czech Republic $1 https://orcid.org/https://orcid.org/0000000287719338
- 245 14
- $a The Different Insulin-Sensitising and Anti-Inflammatory Effects of Palmitoleic Acid and Oleic Acid in a Prediabetes Model / $c D. Miklankova, I. Markova, M. Hüttl, B. Stankova, H. Malinska
- 520 9_
- $a Introduction: Monounsaturated fatty acids (MUFA) are understood to have therapeutic and preventive effects on chronic complications associated with type 2 diabetes mellitus (T2DM); however, there are differences between individual MUFAs. Although the effects of palmitoleic acid (POA) are still debated, POA can regulate glucose homeostasis, lipid metabolism, and cytokine production, thus improving metabolic disorders. In this study, we investigated and compared the metabolic effects of POA and oleic acid (OA) supplementation on glucose and lipid metabolism, insulin sensitivity, and inflammation in a prediabetic model, the hereditary hypertriglyceridemic rat (HHTg). HHTg rats exhibiting genetically determined hypertriglyceridemia, insulin resistance, and impaired glucose tolerance were fed a standard diet. POA and OA were each administered intragastrically at a dose of 100 mg/kg b.wt. for four weeks. Results: Supplementation with both MUFAs significantly elevated insulin and glucagon levels, but only POA decreased nonfasting glucose. POA-treated rats showed elevated circulating NEFA associated with increased lipolysis, lipoprotein lipase gene expression, and fatty acid reesterification in visceral adipose tissue (VAT). The mechanism of improved insulin sensitivity of peripheral tissues (measured as insulin-stimulated lipogenesis and glycogenesis) in POA-treated HHTg rats could contribute increased circulating adiponectin and omentin levels together with elevated FADS1 gene expression in VAT. POA-supplemented rats exhibited markedly decreased proinflammatory cytokine production by VAT, which can alleviate chronic inflammation. OA-supplemented rats exhibited decreased arachidonic acid (AA) profiles and decreased proinflammatory AA-derived metabolites (20-HETE) in membrane phospholipids of peripheral tissues. Slightly increased FADS1 gene expression after OA along with increased adiponectin production by VAT was reflected in slightly ameliorated adipose tissue insulin sensitivity (increased insulin-stimulated lipogenesis). Conclusions: Our results show that POA served as a lipokine, ameliorating insulin sensitivity in peripheral tissue and markedly modulating the metabolic activity of VAT including cytokine secretion. OA had a beneficial effect on lipid metabolism and improved inflammation by modulating AA metabolism.
- 650 _2
- $a adiponektin $7 D052242
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antiflogistika $7 D000893
- 650 _2
- $a kyseliny arachidonové $7 D001095
- 650 _2
- $a cytokiny $7 D016207
- 650 12
- $a diabetes mellitus 2. typu $7 D003924
- 650 _2
- $a mastné kyseliny $x metabolismus $7 D005227
- 650 _2
- $a kyseliny mastné mononenasycené $x farmakologie $x terapeutické užití $7 D005229
- 650 _2
- $a kyseliny mastné neesterifikované $7 D005230
- 650 _2
- $a glukagon $7 D005934
- 650 _2
- $a glukosa $x metabolismus $7 D005947
- 650 _2
- $a zánět $7 D007249
- 650 _2
- $a inzulin $x metabolismus $7 D007328
- 650 12
- $a inzulinová rezistence $7 D007333
- 650 _2
- $a lipoproteinlipasa $7 D008071
- 650 _2
- $a kyselina olejová $x farmakologie $7 D019301
- 650 12
- $a prediabetes $x farmakoterapie $7 D011236
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Markova, Irena $u Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $1 https://orcid.org/https://orcid.org/0000000243317636
- 700 1_
- $a Hüttl, Martina $u Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $1 https://orcid.org/https://orcid.org/0000000224843630
- 700 1_
- $a Stankova, Barbora $u First Faculty of Medicine, Charles University, Prague, Czech Republic $1 https://orcid.org/https://orcid.org/0000000261844878
- 700 1_
- $a Malinska, Hana $u Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $1 https://orcid.org/https://orcid.org/0000000290763399
- 773 0_
- $w MED00181720 $t Journal of diabetes research $x 2314-6753 $g Roč. 2022, č. - (2022), s. 4587907
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36147256 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20221017 $b ABA008
- 991 __
- $a 20221031100257 $b ABA008
- 999 __
- $a ok $b bmc $g 1854247 $s 1175712
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 2022 $c - $d 4587907 $e 20220913 $i 2314-6753 $m Journal of diabetes research $n J Diabetes Res $x MED00181720
- LZP __
- $a Pubmed-20221017